Ticker LaunchIPO · CNSP
CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals, Inc. (CNSP) priced its initial public offering on Nov 8, 2019 at $4.00 per share, raising $850K. At the IPO price its market capitalization was about $62.8M. Sheppard Mullin advised the underwriters.
CNS Pharmaceuticals, Inc. is a preclinical-stage pharmaceutical company, organized in Nevada, developing drug candidates for primary and metastatic brain and central nervous system tumors. Its lead candidate, Berubicin, is an anthracycline aimed at glioblastoma, a type of brain cancer.
- Status
- IPO
- Ticker
- CNSP
- Priced
- Nov 8, 2019
- IPO price
- $4.00
- Raised
- $850K
- Market cap at IPO price
- $62.8M
- First filed
- Jun 28, 2019
- Underwriters' counsel
- Sheppard Mullin
- Sector
- Biotech & pharma
- Country / state
- TX
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
- Shares offered, over-allotment and shares outstanding after the offering
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Jun 28, 2019
- Latest amendment Oct 7, 2019
- Final prospectus (424B4) Nov 8, 2019
- All filings on EDGAR CIK 1729427
Other Biotech & pharma IPOs in 2019
- 89bio, Inc.ETNB · Nov 12, 2019 · $84.9M
- Galera Therapeutics, Inc.GRTX · Nov 8, 2019 · $60M
- Oyster Point Pharma, Inc.OYST · Oct 31, 2019 · $80M
- Phathom Pharmaceuticals, Inc.PHAT · Oct 28, 2019 · $181.7M
- Cabaletta Bio, Inc.CABA · Oct 25, 2019 · $74.8M
- TFF Pharmaceuticals, Inc.TFFP · Oct 25, 2019